Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Director dealings: ProCook chief spends £0.21m on half a million shares

(Sharecast News) - ProCook shares were on their way down on Friday afternoon, after it emerged that its chief executive spent more than £0.21m on shares. The kitchenware retailer disclosed that Daniel O'Neill bought 500,000 shares on Thursday, in an open market transaction on the London Stock Exchange.

O'Neill paid 42.5p for each share, spending a total of £212,500.01.

Following the purchase, ProCook said O'Neill and people connected with him had a total interest in 38,736,902 of its shares, representing 35.5% of its issued capital.

ProCook shares had been hovering between 42p and 43p since surging from around 35p at the beginning of August, but began to slip on Thursday before sliding further in trading so far on Friday.

At 1242 BST, shares in ProCook Group were down 5.11% at 40.33p.

Reporting by Josh White at

Top Director Buys

Procook Group (PROC) Director name: OÂ'Neill,Daniel Amount purchased: 500,000 @ 42.50p Value: £212,500.01

Derwent London (DLN) Director name: Sharma,Sanjeev Amount purchased: 1,261 @ 2,697.60p Value: £34,016.74

Share this article

Related Sharecast Articles

Director dealings: Blue Coast raises stake in Everyman Media
(Sharecast News) - Everyman Media revealed on Thursday that Blue Coast had acquired 50,000 ordinary shares in the AIM-listed cinema group.
Director dealings: Angus Energy CEO ups stake
(Sharecast News) - Angus Energy revealed on Wednesday that chief executive Richard Herbert had acquired 5.0m ordinary shares in the AIM-listed onshore oil and gas development firm.
Director dealings: Abrdn CEO makes share sale
(Sharecast News) - Abrdn revealed on Monday that chief executive Stephen Bird had disposed of 29,942 ordinary shares in the FTSE 250-listed global investment company.
Director dealings: Redx Pharma CEO ups stake
(Sharecast News) - Redx Pharma revealed on Friday that chief executive Lisa Anson had acquired 399,000 ordinary shares in the AIM-listed clinical-stage biopharmaceutical firm.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.